| Kathleen A Mulligan, MD | |
|
1991 Crocker Rd, Suite 310, Westlake, OH 44145-6969 | |
| (440) 617-9114 | |
| (440) 617-9058 |
| Full Name | Kathleen A Mulligan |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 32 Years |
| Location | 1991 Crocker Rd, Westlake, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659320398 | NPI | - | NPPES |
| 000000254178 | Other | OH | ANTHEM BC/BS |
| 070017696 | Other | OH | RAILROAD |
| 0839961 | Medicaid | OH |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Westshore Dermatology Inc | 2163569690 | 2 |
News Archive
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed the sale of approximately $8.75 million of unsecured subordinated 2.0% convertible debentures that are convertible under specified circumstances into existing class B preferred shares.
The flexibility and ability to adapt to changing climates by employing various cultural innovations allowed communities of early humans to survive through a prolonged period of pronounced aridification.
As world nutrition experts gather this week at the WHO headquarters to discuss ways to fight global malnutrition, VOA News examines the growing issues of "undernutrition and obesity, which affect hundreds of millions of people worldwide."
Medications have long been used to treat pain caused by injury or chronic conditions. Unfortunately, most are short-term fixes or cause side effects that limit their use. Researchers at the University of Missouri have discovered a new compound that offers longer lasting painkilling effects, and shows promise as an alternative to current anesthetics.
In December 2011, the U.S. National Science Advisory Board for Biosecurity (NSABB) advised that two research teams that had genetically altered the H5N1 virus to be easily transmissible among ferrets redact some of the research details before publishing in the journals Science and Nature.
› Verified 6 days ago
| Entity Name | Westshore Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831295526 PECOS PAC ID: 2163569690 Enrollment ID: O20091102000274 |
News Archive
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed the sale of approximately $8.75 million of unsecured subordinated 2.0% convertible debentures that are convertible under specified circumstances into existing class B preferred shares.
The flexibility and ability to adapt to changing climates by employing various cultural innovations allowed communities of early humans to survive through a prolonged period of pronounced aridification.
As world nutrition experts gather this week at the WHO headquarters to discuss ways to fight global malnutrition, VOA News examines the growing issues of "undernutrition and obesity, which affect hundreds of millions of people worldwide."
Medications have long been used to treat pain caused by injury or chronic conditions. Unfortunately, most are short-term fixes or cause side effects that limit their use. Researchers at the University of Missouri have discovered a new compound that offers longer lasting painkilling effects, and shows promise as an alternative to current anesthetics.
In December 2011, the U.S. National Science Advisory Board for Biosecurity (NSABB) advised that two research teams that had genetically altered the H5N1 virus to be easily transmissible among ferrets redact some of the research details before publishing in the journals Science and Nature.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen A Mulligan, MD 1991 Crocker Rd, Suite 310, Westlake, OH 44145-6969 Ph: (440) 617-9114 | Kathleen A Mulligan, MD 1991 Crocker Rd, Suite 310, Westlake, OH 44145-6969 Ph: (440) 617-9114 |
News Archive
NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), today announced that it has closed the sale of approximately $8.75 million of unsecured subordinated 2.0% convertible debentures that are convertible under specified circumstances into existing class B preferred shares.
The flexibility and ability to adapt to changing climates by employing various cultural innovations allowed communities of early humans to survive through a prolonged period of pronounced aridification.
As world nutrition experts gather this week at the WHO headquarters to discuss ways to fight global malnutrition, VOA News examines the growing issues of "undernutrition and obesity, which affect hundreds of millions of people worldwide."
Medications have long been used to treat pain caused by injury or chronic conditions. Unfortunately, most are short-term fixes or cause side effects that limit their use. Researchers at the University of Missouri have discovered a new compound that offers longer lasting painkilling effects, and shows promise as an alternative to current anesthetics.
In December 2011, the U.S. National Science Advisory Board for Biosecurity (NSABB) advised that two research teams that had genetically altered the H5N1 virus to be easily transmissible among ferrets redact some of the research details before publishing in the journals Science and Nature.
› Verified 6 days ago
Aziza A Wahby, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4350 Crocker Rd Ste 300, Westlake, OH 44145 Phone: 440-646-1600 Fax: 440-646-1505 | |
Mihir Minesh Shah, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26908 Detroit Rd Ste 103, Westlake, OH 44145 Phone: 440-249-0274 Fax: 440-808-1718 | |
Dr. James M Kasick, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29099 Health Campus Dr, Suite 330, Westlake, OH 44145 Phone: 440-835-6278 Fax: 440-835-6278 | |
Dr. Louis Stephen Kish, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 26410 Center Ridge Rd, Westlake, OH 44145 Phone: 440-835-6194 Fax: 440-892-9160 | |
Dr. Renuka Diwan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 29101 Health Campus Dr, Suite 300, Westlake, OH 44145 Phone: 440-871-9832 Fax: 440-871-0816 | |
Conley Walter Engstrom, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26908 Detroit Rd, Suite 103, Westlake, OH 44145 Phone: 440-482-8323 Fax: 440-808-1606 | |
Michael David Reep, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 26908 Detroit Rd, Suite 103, Westlake, OH 44145 Phone: 440-482-8323 Fax: 440-808-1606 |